A new study shows that the cancer protein MCL1 connects two key hallmarks of cancer: resistance to cell death and altered ...

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides ...

The researchers have succeeded in tracing two classic hallmarks of cancer – the evasion of apoptosis (a form of programmed cell death) and the dysregulation of energy metabolism – back to a common ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...

A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A study published in iMetaMed reveals that the mTOR inhibitor Everolimus treats ulcerative colitis through a two-pronged approach: inhibiting the CLEC4E inflammatory pathway in macrophages and ...

Cells are the basic unit of life and come in many different sizes and shapes. In animals, cell size is exquisitely matched to cell function: the smallest cells (such as red blood cells and sperm) shed ...